Silver-loaded hollow copper sulfide particles for antibacterial therapy

Yue Hou1,2, Fanling Zhang3, Hong Sun1,2

  • 1Translational Medicine Center, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China. chuhongqian@bjxkyy.cn.

Insights

A novel copper sulfide-silver nanoparticle (CuS@Ag) hybrid nanostructure effectively combats antibiotic resistance (AR) through photothermal therapy (PTT). This CuS@Ag material shows potent antibacterial activity against drug-resistant bacteria like Mycobacterium tuberculosis.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Biomedical Engineering

Background:

  • Antibiotic resistance (AR) is a critical global health challenge, driven by antibiotic misuse and leading to severe infections worldwide.
  • Drug-resistant bacteria such as Mycobacterium tuberculosis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa necessitate novel antibacterial strategies.
  • Photothermal therapy (PTT) offers a promising biocompatible approach to overcome AR, but bacterial heat resistance can limit its efficacy.

Purpose of the Study:

  • To develop and evaluate a novel CuS@Ag hybrid nanostructure for enhanced photothermal antibacterial therapy.
  • To investigate the antibacterial efficacy of CuS@Ag against Mycobacterium tuberculosis (model: Bacillus Calmette-Guérin), E. coli, S. aureus, and P. aeruginosa.
  • To assess the combined photothermal and nanoparticle antibacterial effects of the CuS@Ag nanostructure.

Main Methods:

  • A stepwise synthesis involved creating hollow copper sulfide (CuS) nanostructures followed by silver nanoparticle (Ag NP) reduction on the surface, yielding CuS@Ag.
  • In vitro antibacterial activity was tested using Bacillus Calmette-Guérin (BCG) as an M. tb model, E. coli, S. aureus, and P. aeruginosa.
  • Bacterial treatments included CuS@Ag exposure followed by 808 nm laser irradiation and subsequent incubation at 37°C.

Main Results:

  • CuS@Ag demonstrated significant antibacterial activity, achieving a 94.8% rate against BCG with 0.02 mg mL⁻¹ concentration and 6-minute laser exposure.
  • Under identical conditions, E. coli and S. aureus showed 33.5% and 49.4% antibacterial rates, respectively.
  • At a higher concentration (1.02 mg mL⁻¹), CuS@Ag achieved 100% efficacy against BCG, E. coli, S. aureus, and P. aeruginosa, indicating broad-spectrum activity.

Conclusions:

  • The CuS@Ag hybrid nanostructure effectively combines the photothermal properties of CuS with the antibacterial action of Ag NPs.
  • This synergistic approach results in potent antimycobacterial and broad-spectrum antibacterial effects, offering a promising alternative to conventional antibiotics.
  • The developed CuS@Ag nanostructure shows potential for overcoming bacterial heat resistance and combating antibiotic-resistant infections.